Cas­es of se­vere RSV in two Mod­er­na vac­cine can­di­dates' tri­als raise ques­tions about fu­ture

Ahead of an ad­vi­so­ry com­mit­tee meet­ing lat­er this week, the FDA re­vealed that all stud­ies for RSV vac­cines in young chil­dren and in­fants are cur­rent­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.